Literature DB >> 26297101

Economic Evaluations in the Diagnosis and Management of Traumatic Brain Injury: A Systematic Review and Analysis of Quality.

Aziz S Alali1, Kirsteen Burton2, Robert A Fowler3, David M J Naimark4, Damon C Scales3, Todd G Mainprize5, Avery B Nathens6.   

Abstract

BACKGROUND: Economic evaluations provide a unique opportunity to identify the optimal strategies for the diagnosis and management of traumatic brain injury (TBI), for which uncertainty is common and the economic burden is substantial.
OBJECTIVE: The objective of this study was to systematically review and examine the quality of contemporary economic evaluations in the diagnosis and management of TBI.
METHODS: Two reviewers independently searched MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, NHS Economic Evaluation Database, Health Technology Assessment Database, EconLit, and the Tufts CEA Registry for comparative economic evaluations published from 2000 onward (last updated on August 30, 2013). Data on methods, results, and quality were abstracted in duplicate. The results were summarized quantitatively and qualitatively.
RESULTS: Of 3539 citations, 24 economic evaluations met our inclusion criteria. Nine were cost-utility, five were cost-effectiveness, three were cost-minimization, and seven were cost-consequences analyses. Only six studies were of high quality. Current evidence from high-quality studies suggests the economic attractiveness of the following strategies: a low medical threshold for computed tomography (CT) scanning of asymptomatic infants with possible inflicted TBI, selective CT scanning of adults with mild TBI as per the Canadian CT Head Rule, management of severe TBI according to the Brain Trauma Foundation guidelines, management of TBI in dedicated neurocritical care units, and early transfer of patients with TBI with nonsurgical lesions to neuroscience centers.
CONCLUSIONS: Threshold-guided CT scanning, adherence to Brain Trauma Foundation guidelines, and care for patients with TBI, including those with nonsurgical lesions, in specialized settings appear to be economically attractive strategies.
Copyright © 2015 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  cost utility; cost-benefit analysis; cost-effectiveness; economic evaluation; systematic review; traumatic brain injury

Mesh:

Year:  2015        PMID: 26297101     DOI: 10.1016/j.jval.2015.04.012

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  17 in total

1.  Effects of the CarFreeMe Traumatic Injuries, a Community Mobility Group Intervention, to Increase Community Participation for People With Traumatic Injuries: A Randomized Controlled Trial With Crossover.

Authors:  Stacey George; Christopher Barr; Angela Berndt; Rachel Milte; Amy Nussio; Zoe Adey-Wakeling; Jacki Liddle
Journal:  Front Neurol       Date:  2022-07-01       Impact factor: 4.086

2.  Early-Onset Ventilator-Associated Pneumonia in Patients with Severe Traumatic Brain Injury: Incidence, Risk Factors, and Consequences in Cerebral Oxygenation and Outcome.

Authors:  Pierre Esnault; Cédric Nguyen; Julien Bordes; Erwan D'Aranda; Ambroise Montcriol; Claire Contargyris; Jean Cotte; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Henry Boret; Eric Meaudre
Journal:  Neurocrit Care       Date:  2017-10       Impact factor: 3.210

3.  Ability of Fibrin Monomers to Predict Progressive Hemorrhagic Injury in Patients with Severe Traumatic Brain Injury.

Authors:  Pierre Esnault; Quentin Mathais; Erwan D'Aranda; Ambroise Montcriol; Mickaël Cardinale; Pierre-Julien Cungi; Philippe Goutorbe; Christophe Joubert; Arnaud Dagain; Eric Meaudre
Journal:  Neurocrit Care       Date:  2020-08       Impact factor: 3.210

4.  Neuroprotective effects of estrogen in CNS injuries: insights from animal models.

Authors:  Narayan Raghava; Bhaskar C Das; Swapan K Ray
Journal:  Neurosci Neuroecon       Date:  2017-07-04

Review 5.  Biomaterial Scaffolds in Regenerative Therapy of the Central Nervous System.

Authors:  Yanchao Wang; Hong Tan; Xuhui Hui
Journal:  Biomed Res Int       Date:  2018-04-01       Impact factor: 3.411

Review 6.  Incidence, Risk Factors, and Outcomes of Ventilator-Associated Pneumonia in Traumatic Brain Injury: A Meta-analysis.

Authors:  Yating Li; Chenxia Liu; Wei Xiao; Tiantian Song; Shuhui Wang
Journal:  Neurocrit Care       Date:  2020-02       Impact factor: 3.210

7.  Functional and patient-reported outcome versus in-hospital costs after traumatic acute subdural hematoma (t-ASDH): a neurosurgical paradox?

Authors:  Jeroen T J M van Dijck; Thomas A van Essen; Mark D Dijkman; Cassidy Q B Mostert; Suzanne Polinder; Wilco C Peul; Godard C W de Ruiter
Journal:  Acta Neurochir (Wien)       Date:  2019-03-28       Impact factor: 2.216

8.  In-hospital costs after severe traumatic brain injury: A systematic review and quality assessment.

Authors:  Jeroen T J M van Dijck; Mark D Dijkman; Robbin H Ophuis; Godard C W de Ruiter; Wilco C Peul; Suzanne Polinder
Journal:  PLoS One       Date:  2019-05-09       Impact factor: 3.240

Review 9.  Grading and assessment of clinical predictive tools for paediatric head injury: a new evidence-based approach.

Authors:  Mohamed Khalifa; Blanca Gallego
Journal:  BMC Emerg Med       Date:  2019-06-14

10.  Two latent classes of diagnostic and treatment procedures among traumatic brain injury inpatients.

Authors:  Hind A Beydoun; Catherine Butt; May A Beydoun; Shaker M Eid; Alan B Zonderman; Brick Johnstone
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.